Table 6.
Included factor | Disease-free survival | Overall survival | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value | |
Histologic grade | 0.002 | N/A | ||||
Benign versus borderline/malignant | 7.990 | 2.196–29.07 | N/A | N/A | ||
Stromal cellularity | 0.597 | 0.467 | ||||
Mild versus moderate/marked | 0.625 | 0.109–3.569 | 2.862 | 0.169–48.60 | ||
Stromal atypia | 0.886 | 0.708 | ||||
Mild versus moderate/marked | 0.881 | 0.158–4.925 | 0.630 | 0.056–7.049 | ||
Stromal mitosis | 0.854 | 0.437 | ||||
0–4/10 HPF versus >4/10 HPF | 0.782 | 0.057–10.81 | 0.210 | 0.004–10.70 | ||
Stromal overgrowth | 0.029 | 0.006 | ||||
Absent versus present | 7.288 | 1.225–43.35 | 58.10 | 3.116–1083 | ||
Tumor margin | 0.275 | 0.187 | ||||
Circumscribed versus infiltrative | 0.468 | 0.120–1.830 | 0.321 | 0.060–1.732 | ||
PDGFRα (stromal) | 0.867 | 0.050 | ||||
Negative versus positive | 0.879 | 0.193–4.008 | 5.486 | 1.003–30.01 |
HPF, high-power field.